SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-08-108153
Filing Date
2008-05-09
Accepted
2008-05-08 18:25:35
Documents
6
Period of Report
2008-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 512594
2 AMENDED 2008 CORPORATE BONUS PLAN dex1025.htm EX-10.25 43343
3 AMENDMENT NO. 2 TO COLLABORATION AND LICENSE AGREEMENT dex1026.htm EX-10.26 10374
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER - SECTION 302 dex311.htm EX-31.1 7598
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER - SECTION 302 dex312.htm EX-31.2 7819
6 CERTIFICATION OF CEO AND CFO - SECTION 906 dex32.htm EX-32 5035
  Complete submission text file 0001193125-08-108153.txt   588172
Mailing Address 12481 HIGH BLUFF DRIVE SUITE 200 SAN DIEGO CA 92130
Business Address 12481 HIGH BLUFF DRIVE SUITE 200 SAN DIEGO CA 92130 8584361400
CADENCE PHARMACEUTICALS INC (Filer) CIK: 0001333248 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33103 | Film No.: 08815518
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1